@docroham profile picture
Roham Zamanian @docroham

Professor of Medicine ; Director Adult Pulmonary Hypertension Program ; Associate Director Vera Moulton Wall Center; clinical trialist ; photographer.

Joined September 2012
  • Tweets 652
  • Following 617
  • Followers 1,021
134 Photos and videos
Excited to have been part of a superb Phase 2 study of Seralutinib in PAH. Read it below: sciencedirect.com/science/ar…

1
3
14
831
Incredible. Hats off to all scientists/investigators/patients(!). Excited to have access to therapy w such a potential. BUT!!!! Inaccurate& misleading news will NOT help our field or patients. Opinion is not fact! @PVRI @Viniciodjperez @AlbertaPHdoc cnn.com/2024/03/26/health/wi…

FDA approves new drug that may help stop a rare, fatal condition that doctors call a ‘ticking time...

When doctors told Katrina Barry that she had a rare and serious condition called pulmonary arterial hypertension, or PAH, they warned her not to Google it.

cnn.com
2
18
3,416
A pleasure to help pave to define disease modification in PAH. An honor to work with a superb group of colleagues - Exciting think-tank style collab, along with the ever-so-important patient perspective pubmed.ncbi.nlm.nih.gov/3847… @PHatStanford @AlbertaPHdoc @PVRI

Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension - PubMed

Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension

pubmed.ncbi.nlm.nih.gov
Vinicio de Jesus Perez, MD FAHA FCCP ATSF@Viniciodjperez
12 Mar 2024
Are we ready for “disease modification”? We got the scoop! Check out the paper-available today online.
5
13
1,420
Roham Zamanian retweeted
Vinicio de Jesus Perez, MD FAHA FCCP ATSF@Viniciodjperez
12 Mar 2024
Are we ready for “disease modification”? We got the scoop! Check out the paper-available today online.
Jason Weatherald MD@AlbertaPHdoc
12 Mar 2024
What does “disease modification” mean in #PulmonaryArterialHypertension? Honoured to be part of this perspective in @ATSBlueEditor led by @Viniciodjperez & @docroham atsjournals.org/doi/abs/10.1… @VApccm @BogaardHarm @mpsotka @PHACanada @PHAssociation @PVRI @UAlberta_DoM
1
4
8
2,856
Difficult news to hear….a huge loss for the field and our community. On behalf of @PHatStanford, our deepest condolences to the Newman family and Vanderbilt colleagues. His legacy will live on thru his contributions to our field and the many he has mentored.
The Pulmonary Vascular Research Institute
@PVRI
21 Feb 2024
The PVRI is deeply saddened by the loss of Dr John Newman, a cherished member of the Pulmonary Vascular Disease community. His dedication and expertise have left an indelible mark on our field. Sending heartfelt condolences to his loved ones and colleagues during this time.
1
10
673
RIP Major Brian Shul! Incredible story of an aviator. - resilience, courage, and grit. Spoke at our @PHatStanford pulmonary hypertension symposium a few years ago…. nytimes.com/2023/05/30/us/br…

Brian Shul Dies at 75; Fighter Pilot Who Flew World’s Fastest Plane (Gift Article)

He was near death after his plane was shot down in the Vietnam War but survived to fly the world’s fastest and highest-altitude jet.

nytimes.com
1
3
355
Social hour at ATS with Stanford PH team & friends @StanfordPACCM @PHatStanford
2
2
38
1,665
Dr Andrew Sweatt - The Jane Moris Award recipient @ATS_PC Congratulations Andy!!!!!! Made us proud. @StanfordPACCM @PHatStanford
1
25
793
Congratulations to Andy Sweatt & Adam Andruska for amazing presentations on vasoreactivity in PAH & PVOD risk score. Did us proud!! @ATS_PC @atscommunity @StanfordPACCM
1
14
620
1
5
551
Replying to @docroham
@docroham Thanks for the invitation and wonderful discussions. #DIPH #Stanford
1
2
6
400
DIPH Symposium PVOD induced by alkylating agents & solvents by Prof Humbert @Inserm @PHatStanford @StanfordPACCM
3
15
659
Roham Zamanian retweeted
Jason Weatherald MD@AlbertaPHdoc
14 Apr 2023
Replying to @OSitbon
@OSitbon discusses the approach to Dasatinib-associated PAH at the @Stanford Drug Induced PH symposium 1️⃣Stop the drug! 2/3 will resolve with discontinuation alone 2️⃣Treatment based on risk/severity. @docroham @Viniciodjperez @pvri
5
15
1,833
Roham Zamanian retweeted
Vinicio de Jesus Perez, MD FAHA FCCP ATSF@Viniciodjperez
14 Apr 2023
More pics from the Drug-induced PH streaming NOW at Stanford.
1
16
600
Roham Zamanian retweeted
Jason Weatherald MD@AlbertaPHdoc
13 Apr 2023
Kicking off the @Stanford Drug Induced #PulmonaryHypertension symposium Fantastic lineup ahead. Thanks to @docroham for the invitation #DIPH @PHatStanford
1
4
21
2,020
DIPH 2023 @StanfordPACCM @PHatStanford
2
9
419
Lang先生によるcardio-oncologyのレクチャーです #DIPH #Stanford
1
5
466
Roham Zamanian retweeted
Montani David@Montanidavid
14 Apr 2023
Happy to discuss genetics in drugs-associated PAH at @Stanford University. Thanks to @docroham for the invitation #DIPH @PHatStanford @pulmotension @RespiFIL @InsermU999
2
3
16
782
Second day of DIPH Symposium 2023 starts at 8 am PST. First day was amazing, 2nd will be exciting. Join us! livestream.com/accounts/1973… Or youtube.com/live/j54HG3dBTgU…
1
13
662
Drug Induced Pulmonary Hypertension Symposium at Stanford is 1 week away! HYBRID (In person & Live Streaming). Not too late to join us. Registration is still open. @PHatStanford @StanfordPACCM @StanfordDeptMed
6
15
1,198
Load more